Proyectos de ley › 88.ª Asamblea General

HF 2465Murió al terminar la sesión · 20 de febrero de 2020

Relating to pharmacy benefit managers and the cost of prescription drug benefits, and including applicability provisions

Temas:Business & economyHealth carePrescription drug prices

Dónde está ahora

  1. Hecho: Presentado20 de febrero de 2020
  2. Se detuvo: SubcomitéMurió al terminar la Asamblea General
  3. Sigue: Comité de la Cámara
  4. Sigue: Lo aprueba la Cámara
  5. Sigue: Comité del Senado
  6. Sigue: Lo aprueba el Senado
  7. Sigue: A gobernador(a)
  8. Sigue: Firmado como ley

Murió al terminar la sesión La sesión de 2020 terminó el 14 de junio de 2020, la última sesión ordinaria de la Asamblea General. Los proyectos que no pasaron por ambas cámaras murieron. ¿Qué es el embudo (funnel)?

Qué contiene

La explicación oficial está en inglés; todavía no hay resumen en palabras sencillas.

This bill relates to pharmacy benefit managers, health carriers, and the cost of prescription drug benefits. “Pharmacy benefit manager” is defined in the bill as a person who, pursuant to a contract or an employment relationship with a health carrier, either directly or through an affiliate or intermediary, manages a prescription drug benefit provided by the health carrier. The bill defines a “health carrier” as an entity subject to the insurance laws and regulations of this state, or subject to the jurisdiction of the commissioner, including an insurance company offering sickness and accident plans, a health maintenance organization, a nonprofit health service corporation, a plan established pursuant to Code chapter 509A for public employees, or any other entity providing a plan of health insurance, health care benefits, or health care services.

Lea la explicación completa

The bill provides that if a health carrier provides a prescription drug benefit to a covered person under a health benefit plan, and the prescription drug benefit is managed by a pharmacy benefit manager, the pharmacy benefit manager must reduce, at the point of sale, any cost sharing for a prescription drug by either a dollar amount that equals not less than percent of the aggregate rebates received by the pharmacy benefit manager for that particular prescription drug, or a dollar amount greater than that amount. The bill prohibits a pharmacy benefit manager from increasing a participating pharmacy’s, participating pharmacist’s, or other participating dispenser’s cost of participation to offset the required reduction in cost sharing. A pharmacy benefit manager is prohibited from disclosing any information regarding the actual amount of rebates the pharmacy benefit manager received for a specific drug, or from a specific pharmaceutical manufacturer in order to comply with the cost-sharing requirement. Rebate information is protected as a trade secret and is a confidential record. A pharmacy benefit manager is also required to have an agreement with the pharmacy benefit manager’s third-party vendors and downstream entities as necessary to ensure the information is protected as a trade secret. The bill requires the commissioner of insurance to adopt rules as necessary to administer the provisions of the bill. The bill also allows the commissioner to take any action within the commissioner’s authority to enforce compliance with the provisions of the bill. The bill is applicable to health benefit plans that are delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2021.

Texto completo del proyecto (en inglés)1

Lo que cambia del Código de Iowa (Iowa Code)

Crea§514M.1§514M.2§514M.3§514M.4§514M.5

Cómo funciona el Código2

Cabildeo

0 a favor · 4 en contra · 3 indecisos · Quiénes →